| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-07 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |